D-Index & Metrics Best Publications

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Biology and Biochemistry D-index 47 Citations 8,271 111 World Ranking 14660 National Ranking 6132

Overview

What is he best known for?

The fields of study he is best known for:

  • Internal medicine
  • Enzyme
  • Mitochondrion

Hagir B. Suliman mainly investigates Mitochondrial biogenesis, Mitochondrion, Molecular biology, Oxidative phosphorylation and Heme oxygenase. Hagir B. Suliman focuses mostly in the field of Mitochondrial biogenesis, narrowing it down to matters related to Intensive care and, in some cases, Mitochondrial Size. His Mitochondrion study combines topics from a wide range of disciplines, such as Internal medicine, Endothelial NOS and Endocrinology.

His study looks at the relationship between Molecular biology and fields such as NRF1, as well as how they intersect with chemical problems. His Oxidative phosphorylation research includes themes of Oxidative stress and TFAM. His study on HMOX1 is often connected to Doxorubicin as part of broader study in Heme oxygenase.

His most cited work include:

  • Heme Oxygenase-1 Regulates Cardiac Mitochondrial Biogenesis via Nrf2-Mediated Transcriptional Control of Nuclear Respiratory Factor-1 (351 citations)
  • EXTRACELLULAR SUPEROXIDE DISMUTASE IN THE AIRWAYS OF TRANSGENIC MICE REDUCES INFLAMMATION AND ATTENUATES LUNG TOXICITY FOLLOWING HYPEROXIA (258 citations)
  • Survival in critical illness is associated with early activation of mitochondrial biogenesis. (256 citations)

What are the main themes of his work throughout his whole career to date?

Hagir B. Suliman spends much of his time researching Mitochondrial biogenesis, Mitochondrion, Molecular biology, Cell biology and Oxidative stress. Hagir B. Suliman focuses mostly in the field of Mitochondrial biogenesis, narrowing it down to topics relating to Heme oxygenase and, in certain cases, Hemeprotein. The concepts of his Mitochondrion study are interwoven with issues in Endocrinology, Internal medicine, SOD2 and Pathology.

His Molecular biology research is multidisciplinary, incorporating elements of NFKB1, Promoter, Lung injury and Toll-like receptor. His Cell biology research is multidisciplinary, incorporating perspectives in Inflammation, mitochondrial fusion, Cell damage and Mitophagy. Hagir B. Suliman works mostly in the field of Oxidative stress, limiting it down to concerns involving Oxidative phosphorylation and, occasionally, Glutathione and Cytochrome c oxidase.

He most often published in these fields:

  • Mitochondrial biogenesis (36.70%)
  • Mitochondrion (33.03%)
  • Molecular biology (24.77%)

What were the highlights of his more recent work (between 2012-2021)?

  • Mitochondrial biogenesis (36.70%)
  • Mitochondrion (33.03%)
  • Sepsis (12.84%)

In recent papers he was focusing on the following fields of study:

Hagir B. Suliman mainly focuses on Mitochondrial biogenesis, Mitochondrion, Sepsis, Molecular biology and Cell biology. His Mitochondrial biogenesis study focuses on TFAM in particular. His work in TFAM covers topics such as NRF1 which are related to areas like Tumor necrosis factor alpha, Andrology and Heme oxygenase.

His Mitochondrion study introduces a deeper knowledge of Biochemistry. Hagir B. Suliman combines subjects such as Dialysis, Lung injury, Lung and Immunohistochemistry with his study of Sepsis. His Cell biology study combines topics from a wide range of disciplines, such as mitochondrial fusion, Oxidative stress and Mitophagy.

Between 2012 and 2021, his most popular works were:

  • Mitochondrial Quality Control as a Therapeutic Target (139 citations)
  • Heme oxygenase-1 regulates mitochondrial quality control in the heart (76 citations)
  • Redox regulation of mitophagy in the lung during murine Staphylococcus aureus sepsis (58 citations)

In his most recent research, the most cited papers focused on:

  • Internal medicine
  • Enzyme
  • Biochemistry

His primary scientific interests are in Mitochondrial biogenesis, Mitochondrion, Cell biology, Mitophagy and Molecular biology. Mitochondrial biogenesis is a subfield of Biochemistry that Hagir B. Suliman studies. His Biochemistry research includes elements of Reperfusion injury and NFE2L2.

His research in Cell biology intersects with topics in mitochondrial fusion and Oxidative stress. His study looks at the relationship between Molecular biology and topics such as TFAM, which overlap with NRF1, FIS1 and Mitochondrial fission. Hagir B. Suliman works mostly in the field of Autophagy, limiting it down to topics relating to Programmed cell death and, in certain cases, HMOX1, Cardiac fibrosis, Autophagosome, Lung injury and Bronchoalveolar lavage.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Heme Oxygenase-1 Regulates Cardiac Mitochondrial Biogenesis via Nrf2-Mediated Transcriptional Control of Nuclear Respiratory Factor-1

Claude A. Piantadosi;Martha Sue Carraway;Abdelwahid Babiker;Hagir B. Suliman.
Circulation Research (2008)

625 Citations

Survival in critical illness is associated with early activation of mitochondrial biogenesis.

Jane E. Carré;Jean Christophe Orban;Lorenza Re;Karen Felsmann.
American Journal of Respiratory and Critical Care Medicine (2010)

430 Citations

EXTRACELLULAR SUPEROXIDE DISMUTASE IN THE AIRWAYS OF TRANSGENIC MICE REDUCES INFLAMMATION AND ATTENUATES LUNG TOXICITY FOLLOWING HYPEROXIA

Rodney J. Folz;Amir M. Abushamaa;Hagir B. Suliman.
Journal of Clinical Investigation (1999)

343 Citations

Extracellular superoxide dismutase.

Eva Nozik-Grayck;Hagir B. Suliman;Claude A. Piantadosi.
The International Journal of Biochemistry & Cell Biology (2005)

327 Citations

Lipopolysaccharide induces oxidative cardiac mitochondrial damage and biogenesis

Hagir B. Suliman;Karen E. Welty-Wolf;Martha Sue Carraway;Lynn Tatro.
Cardiovascular Research (2004)

325 Citations

The CO/HO system reverses inhibition of mitochondrial biogenesis and prevents murine doxorubicin cardiomyopathy

Hagir B. Suliman;Martha Sue Carraway;Abdelwahid S. Ali;Chrystal M. Reynolds.
Journal of Clinical Investigation (2007)

309 Citations

Mitochondrial transcription factor-A induction by redox activation of nuclear respiratory factor-1

Claude A. Piantadosi;Hagir B. Suliman.
Journal of Biological Chemistry (2006)

295 Citations

Heme Oxygenase-1 Couples Activation of Mitochondrial Biogenesis to Anti-inflammatory Cytokine Expression *

Claude A. Piantadosi;Crystal M. Withers;Raquel R. Bartz;Nancy Chou MacGarvey.
Journal of Biological Chemistry (2011)

268 Citations

Mitochondrial Quality Control as a Therapeutic Target

Hagir B. Suliman;Claude A. Piantadosi.
Pharmacological Reviews (2016)

250 Citations

Lipopolysaccharide stimulates mitochondrial biogenesis via activation of nuclear respiratory factor-1.

Hagir B. Suliman;Martha S. Carraway;Karen E. Welty-Wolf;A.Richard Whorton.
Journal of Biological Chemistry (2003)

241 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Hagir B. Suliman

Augustine M. K. Choi

Augustine M. K. Choi

Cornell University

Publications: 34

Mervyn Singer

Mervyn Singer

University College London

Publications: 32

Leo E. Otterbein

Leo E. Otterbein

Beth Israel Deaconess Medical Center

Publications: 26

Stefan W. Ryter

Stefan W. Ryter

Cornell University

Publications: 24

Tim D. Oury

Tim D. Oury

University of Pittsburgh

Publications: 23

Marcel Levi

Marcel Levi

University of Amsterdam

Publications: 21

Claude A. Piantadosi

Claude A. Piantadosi

Duke University

Publications: 20

James D. Crapo

James D. Crapo

National Jewish Health

Publications: 18

Anna Mae Diehl

Anna Mae Diehl

Duke University

Publications: 16

Kurt R. Stenmark

Kurt R. Stenmark

University of Colorado Anschutz Medical Campus

Publications: 15

Albena T. Dinkova-Kostova

Albena T. Dinkova-Kostova

University of Dundee

Publications: 15

Marcus J. Schultz

Marcus J. Schultz

University of Amsterdam

Publications: 12

Steven R. Kleeberger

Steven R. Kleeberger

National Institutes of Health

Publications: 12

Vuokko L. Kinnula

Vuokko L. Kinnula

Helsinki University Hospital

Publications: 11

Michael Berk

Michael Berk

Deakin University

Publications: 11

Hyman M. Schipper

Hyman M. Schipper

McGill University

Publications: 11

Trending Scientists

Derui Ding

Derui Ding

University of Shanghai for Science and Technology

Rino Choi

Rino Choi

Inha University

Zhangquan Peng

Zhangquan Peng

Chinese Academy of Sciences

Simon Lacoste-Julien

Simon Lacoste-Julien

University of Montreal

Bernard Meunier

Bernard Meunier

Guangdong University of Technology

Kiitiro Utimoto

Kiitiro Utimoto

Kyoto University

Takashi Hashimoto

Takashi Hashimoto

Shinshu University

Hermie J. M. Harmsen

Hermie J. M. Harmsen

University Medical Center Groningen

Edward A. Clark

Edward A. Clark

University of Washington

Pasi Kolari

Pasi Kolari

University of Helsinki

Junhong Wang

Junhong Wang

University at Albany, State University of New York

Stephen R. Leeder

Stephen R. Leeder

University of Sydney

Martin A. Schreiber

Martin A. Schreiber

Oregon Health & Science University

Patrick Maisonneuve

Patrick Maisonneuve

European Institute of Oncology

David Tall

David Tall

University of Warwick

Roberto A. Weber

Roberto A. Weber

University of Zurich

Something went wrong. Please try again later.